ABSTRACT
Doxorubicin (Dox) is a highly potent chemotherapy drug. Despite its efficacy, Dox's clinical application is limited due to its association with significant complications, namely cardiotoxicity and the risk of heart failure. Recent intriguing findings by Ozcan et al. indicate that alternate-day fasting (ADF) significantly exacerbates the cardiotoxicity of Dox.
PMID:37246117 | DOI:10.1016/j.tem.2023.05.003
20:44
20:44
20:44
Next messages
No comments:
Post a Comment
اكتب تعليق حول الموضوع